昌吉人流手术多少钱昌吉昌吉试纸两个红杠是什么意思,昌吉包皮手术要多久,昌吉怀孕初期多久能测出来,昌吉哪家妇科医院做流产好,昌吉哪家医院做包皮做的好,昌吉到哪做处女膜修复好,昌吉男人该怎么提高性能力

BEIJING, Sept. 14 (Xinhuanet) -- Facebook unveiled a new feature called "smart lists" on Tuesday, giving its users an easier way to share photos, posts and updates with smaller groups of friends.The new function, which commences on Wednesday, borrows from the success of the Circles feature of Google+, which allows users to categorize friends into groups.With the new feature, Facebook can automatically put your friends into groups, with the first four being work, school, family and city, based on the information of colleges, workplaces and geographic locations in users' profiles.The feature is optional to use, and the lists are customizable."This is really something we have been working on for four years," Facebook director of product management Blake Ross told AFP, adding "We think this is the way people will make lists going forward."In the meantime, the social networking site has also come up with "close friends" and "acquaintances" options.People can read the updates of their "close friends" more prominently in their news feed and just big news of their "acquaintances", according to Naomi Gleit, the director of product at Facebook who worked on the new feature.

GENEVA, Aug. 12 (Xinhua) -- 18 people seeking treatment at hospitals in Somalia had been confirmed cholera positive through laboratory tests, the Geneva based World Health Organization (WHO) said on Friday.The 18 positive cases were detected out of 30 stool samples collected from patients seeking treatment at hospitals for acute watery diarrhea, a symptom that could result from cholera, WHO spokesperson Tarek Jasarevic told reporters.All confirmed cases, including residents of Mogadishu district and those among internally displaced persons (IDPs), were said to be tested positive for the Vibrio cholera serotype "inaba", which had been the predominant serotype in Somalia for the past three years."These results are an alarming reminder of the critical situation in Mogadishu and other parts of Southern, Central Somalia, (which are) still experiencing drought, population displacement and conflict," Jasarevic said.WHO has reported a dramatic increase of acute watery diarrhea cases in Somalia.In June and July alone, 1,633 acute watery diarrhea cases had been registered in Banadir Hospital, Mogadishu, representing 38 percent of all reported cases in 2011, and a sharp rise comparing with the same period last year.The United Nations public health arm said the situation was related to poor sanitation and limited access to safe water in numerous informal IDP settlements and a limited capacity of existing health partners to access those settlements and provide essential health services.In addition, the high number of malnourished children due to the ongoing famine increased the susceptibility to waterborne diseases.

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

BEIJING, Sept. 14 (Xinhuanet) -- Scientists had discovered the fossils of a new species of ancient carnivorous fish, National Geographic reported Monday.The newly-found ancient fish, "Laccognathus embryi", is a 1.8-meter-long predator, which was "waiting to lunge out to grab whatever was in front of it," said study co-author Ted Daeschler, a vertebrate zoologist at the Academy of Natural Sciences in Philadelphia, the U.S..It had a jaw filled with sharp teeth that were 1.5 inches long, the Journal of Vertebrate Paleontology described.The fish lived in the Devonian period, 415 to 360 million years ago, which "was a fish-eats-fish kind of world," Daeschler said. "There was a real arms race going. If you didn't have good armor on your body, you were very vulnerable.""It's not just finding the animal - it's also placing the animal in its evolutionary crucible," Daeschler added.Its closest living relative is the lungfish which can survive in the drought, scientists said.Scientists hope the finding can help in their study on the revolution of fishes as well as other species.

WASHINGTON, Sept. 14 (Xinhua) -- Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published Wednesday in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells.The endometrium or uterine lining, is a source of adult stem cells. These cells generate uterine tissue each month as part of the menstrual cycle. Like other stem cells, however, they can divide to form other kinds of cells.Led by Yale Professor Hugh Taylor, the researchers bathed endometrial stem cells in cultures containing special nutrients and growth factors. Responding to these substances, the endometrial stem cells adopted the characteristics of beta cells in the pancreas that produce insulin. Over the course of a three- week incubation process, the endometrial stem cells took on the shape of beta cells and began to make proteins typically made by beta cells. Some of these cells also produced insulin.After a meal, the body breaks food down into components like the sugar glucose, which then circulates in the blood. In response, beta cells release insulin, which allows the body's cells to take in the circulating glucose. In this study, Taylor and his team exposed the mature stem cells to glucose and found that, like typical beta cells, the cultured cells responded by producing insulin. The team then injected diabetic mice with the mature, insulin-making stem cells. The mice had few working beta cells and very high levels of blood glucose.Mice that did not receive the stem cell therapy continued having high blood sugar levels, developed cataracts and were lethargic. In contrast, mice that received the cell therapy were active and did not develop cataracts, but the animals' blood sugar levels remained higher than normal.The Yale team's findings suggest that endometrial stem cells could be used to develop insulin-producing islet cells, which are found in the pancreas. These islet cells could then be used to advance the study of islet cell transplantation to treat people with diabetes.Taylor said in a statement that the next step in the research will be to verify how long this treatment remains effective.